Mersana Therapeutics, Inc.
Price Action
Technical Summary
STAGE 2 UPTRENDMersana Therapeutics, Inc. is in a confirmed Stage 2 uptrend, with price holding above all major moving averages and trend structure remaining intact. Relative strength is leading (RS Rating: 97), indicating clear outperformance against the broad market. Earnings growth of 35% provides fundamental context to the price action. However, with RSI at 79, the stock is extended and may be prone to a short-term pullback.
Trend Template (Minervini)
Price vs Moving Averages
| Period | Value | Spread | Signal |
|---|---|---|---|
| 20 SMA | $28.73 | +1.20% | ABOVE |
| 50 SMA | $22.86 | +27.18% | ABOVE |
| 100 SMA | $15.45 | +88.19% | ABOVE |
| 150 SMA | $13.01 | +123.50% | ABOVE |
| 200 SMA | $11.99 | +142.58% | ABOVE |
Price Performance
Technical Indicators
Risk Profile
Volume Analysis
Earnings Momentum
Growth Trends
Compounded Sales Growth
Compounded Profit Growth
Stock Price CAGR
Return on Equity
Key Metrics
Frequently Asked Questions
Is MRSN in an uptrend right now?
MRSN has a trend score of 4/4 based on Minervini's Stage Analysis. Yes, MRSN is in a Stage 2 uptrend with price above all major moving averages (50, 100, 150, 200 SMA) properly stacked.
Is MRSN overbought or oversold?
MRSN's RSI (14) is 79. The stock is in overbought territory (RSI > 70), which may signal a pullback.
Is MRSN outperforming the market?
MRSN has a Relative Strength (RS) Rating of 97 out of 99. Yes, MRSN is a market leader, outperforming 97% of all stocks over the past 12 months.
Where is MRSN in its 52-week range?
MRSN is trading at $29.08, which is 96% of its 52-week high ($30.39) and 95% above its 52-week low ($5.21).
How volatile is MRSN?
MRSN has a Beta of 1.59 and 52-week volatility of 78%. It's more volatile than the S&P 500 - expect bigger swings.